These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6415852

  • 1. DDAVP: does the drug have a direct effect on the vessel wall?
    Barnhart MI, Chen S, Lusher JM.
    Thromb Res; 1983 Jul 15; 31(2):239-53. PubMed ID: 6415852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
    Porta M.
    Diabetologia; 1982 Nov 15; 23(5):452-5. PubMed ID: 6816652
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI, Lusher JM.
    J Pediatr; 1983 Feb 15; 102(2):228-33. PubMed ID: 6401806
    [Abstract] [Full Text] [Related]

  • 10. DDAVP stimulates prostacyclin production.
    Belch JJ, Small M, McKenzie F, Hill PA, Lowe GD, McIntyre DE, Forbes CD, Prentice CR.
    Thromb Haemost; 1982 Apr 30; 47(2):122-3. PubMed ID: 6808693
    [Abstract] [Full Text] [Related]

  • 11. The use of desmopressin (DDAVP) in the preparation of improved factor VIII concentrate.
    Mikaelsson M, Nilsson IM, Cedergren B, Jonsson S, Rydberg L, Wiechel B.
    Scand J Haematol Suppl; 1984 Apr 30; 40():93-101. PubMed ID: 6433478
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL, Israels ED, Gerrard JM, Cheang MS, Watson CM, Bishop AJ, Schroeder ML.
    Lancet; 1984 May 26; 1(8387):1145-8. PubMed ID: 6144876
    [Abstract] [Full Text] [Related]

  • 14. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL, Doyle JJ, Israels ED, Winter JS, Cheang MS, Walker RD, Bishop AJ.
    Lancet; 1985 Jun 08; 1(8441):1293-4. PubMed ID: 2860491
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen.
    Ghosh S, Rao AK.
    Thromb Res; 1993 Jun 01; 70(5):417-22. PubMed ID: 7690994
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
    Brommer EJ, Derkx FH, Barrett-Bergshoeff MM, Schalekamp MA.
    Thromb Haemost; 1984 Feb 28; 51(1):42-4. PubMed ID: 6426080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.